2026-07-24 Arista
Skaļruņi
nodaļas
-
0:00Nodaļa 1: I think early babies took some. 299s · Speaker 2
I think early babies took some. Yeah. and then and then we brought this together again andrea because yesterday yesterday was black right and based upon what we want to do and deliver our roll -up this afternoon i wanted to before we even s…
-
5:00Nodaļa 2: So let's start then with just getting, so the QI, is there any question regarding the QI? 298s · Speaker 2
So let's start then with just getting, so the QI, is there any question regarding the QI? Are you clear? Yeah. the qi yesterday that we discussed so thanks again for all the work that went in to get this to the stage now do we do we have an…
-
10:00Nodaļa 3: What do you think will be? 297s · Speaker 1
What do you think will be? What do we need to do now? Will it impact your organization? Maybe they just want to say, oh no, that's fine. We just need to do educational education. That would be the best. That would be the best. All right. Al…
-
15:00Nodaļa 4: in the first product, product, phase one, and then you're going to get it. 299s · Speaker 2
in the first product, product, phase one, and then you're going to get it. I just remember where it comes from, 36 and 24, there are two substances. Yeah, yeah, yeah. The second substance does not fit, but when the CR, you mentioned does no…
-
20:00Nodaļa 5: So, could we see those products? 300s · Speaker 1
So, could we see those products? And that means what we're producing today in Q4, we need to get this updated before we continue to, for the 24 and body. We need to continue to produce that. We need to get those products, IBD updated before…
-
25:00
that substance s1024 starts to be produced that's what we're going to send to all those product countries where is the assessment that says it's okay We have an impact assessment regulator for that one. Thank you. hey guys can i talk to you…